Related Experiment Videos
Historical overview of generic medication policy
F J Ascione1, D M Kirking, C A Gaither
1College of Pharmacy, University of Michigan, Ann Arbor 48109-1065, USA. fascione@umich.edu
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|August 7, 2001
Summary
The use of generic drugs has a long history of controversy, primarily driven by economic factors and debates over drug quality and bioequivalence. Despite ongoing debates, generic drug use is now a standard part of healthcare.
Area of Science:
- Pharmacoeconomics
- Pharmaceutical policy
- Drug regulation
Background:
- The historical use of generic drugs has been marked by persistent controversies.
- These disputes stem from various perspectives, including economic, professional, and scientific viewpoints.
Observation:
- Economic conflicts arise from brand-name manufacturers protecting patents against groups seeking lower-cost medications.
- Professional conflicts involve pharmacists' roles in drug product selection.
- Scientific debates center on bioequivalence and product quality, with differing opinions between brand manufacturers and other stakeholders.
Findings:
- Generic drug utilization has significantly increased over the last 50 years, becoming an accepted component of healthcare.
- Despite acceptance, the substantial economic implications ensure continued controversy.
Implications:
- Understanding the historical context of generic drug controversies is crucial for policy-making.
- Future healthcare policies must address the economic drivers of generic drug debates.
- Continued scrutiny of bioequivalence and quality assurance remains essential for public trust and patient safety.